Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?—A propensity score analysis
Huaqiang Ouyang(Tianjin Medical University Cancer Institute and Hospital), Zhanyu Pan(Tianjin Medical University Cancer Institute and Hospital), Weidong Ma(Research Institute of Animal Husbandry), Anna Sandström Gerdtsson(Medicon Village), Donglin Liu(Boston University), Xiangli Jiang(Tianjin Medical University Cancer Institute and Hospital)
Cited by 1
Related Papers
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
|Bioconjugate Chemistry|2015|302
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
|The Lancet Respiratory Medicine|2022|145
Systematic variation in mRNA 3′-processing signals during mouse spermatogenesis
|Nucleic Acids Research|2006|135
Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells
|Cancer Research|2017|83
Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis
|Cell Death and Differentiation|2018|80